Navigation Menu

Clinical Trial External Search

Children (age < 18 years)
Adults (age >= 18 years)

Researcher Profile

Researcher Display

Cristina Truica, MD

Cristina Truica, MD

Associate Professor, Department of Medicine
Director of Breast Medical Oncology, Division of Hematology and Oncology
Center for Cannabis and Natural Product Pharmaceuticals (CCNPP)
Scientific Program:Next-Generation Therapies
Disease Teams:
Cancer Institute, Breast Cancer Team

Research Interests

  • Breast Neoplasms
  • Neoplasms
  • Therapeutics
  • Aromatase Inhibitors
  • Circulating Neoplastic Cells
  • Drug Therapy
  • Exercise
  • exemestane
  • Immunotherapy
  • Education
  • Equipment and Supplies
  • Safety

Clinical Trials

A Phase 3 Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients with Hormone Receptor-Positive (HR+)/Human Epidermal Growth Factor Receptor 2-Negative (HER2-) (HER2 IHC0 or HER2-low [IHC 1+, IHC 2+/ISH-]) Inoperable, Locally Advanced, or Metastatic Breast Cancer and Have Received Endocrine Therapy
General Protocol for the Acquisition of Whole Blood for the Detection and Characterization of Circulating Tumor Cells and/or Tumor Specific Immunity/Immune Cell Activation for any Malignancy at any Stage of Disease
CCTG MA.39:Tailor RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive and T3N0 Breast Cancer
A Phase 3 Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Who Have Residual Invasive Disease in the Breast and/or Axillary Lymph Nodes at Surgical Resection Following Neoadjuvant Systemic Therapy(TROPION-Breast03)
NRG-BR009: A Phase III Adjuvant Trial Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression plus Endocrine Therapy in Premenopausal Patients with pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score (OFSET)
NRG-BR007: A Phase III Clinical Trial Evaluating Deescalation of Breast Radiation for Conservative Treatment of Stage I, Hormone sensitive, HER2- Negative Oncotype recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
An Open Label, Phase II Trial of Pre-operative Neratinib and Endocrine Therapy with Trastuzumab in Triple Positive Breast Cancers
Attitudes towards cannabis use in the PSCI cancer population

Recent Publications


Derbes, R, Hakun, J, Elbich, D, Master, L, Berenbaum, S, Huang, X, Buxton, OM, Chang, AM, Truica, CI & Sturgeon, KM 2024, 'Design and methods of the mobile assessment of cognition, environment, and sleep (MACES) feasibility study in newly diagnosed breast cancer patients', Scientific reports, vol. 14, no. 1, 8338.


Bluethmann, SM, Flores, E, Grotte, M, Heitzenrater, J, Truica, CI, Olsen, NJ, Sciamanna, C & Schmitz, KH 2023, 'Adapting an Evidence-Based Exercise and Education Program for Older Breast Cancer Survivors for the REJOIN Trial', Journal of Aging and Physical Activity, vol. 31, no. 1, pp. 59-67.
Gordon, BR, Qiu, L, Doerksen, SE, Kanski, B, Lorenzo, A, Truica, CI, Vasekar, M, Wang, M, Winkels, RM, Abdullah, S & Schmitz, KH 2023, 'Addressing metastatic individuals everyday: Rationale and design of the nurse AMIE for Amazon Echo Show trial among metastatic breast cancer patients', Contemporary Clinical Trials Communications, vol. 32, 101058.
Schmitz, KH, Kanski, B, Gordon, B, Caru, M, Vasakar, M, Truica, CI, Wang, M, Doerksen, S, Lorenzo, A, Winkels, R, Qiu, L & Abdullah, S 2023, 'Technology-based supportive care for metastatic breast cancer patients', Supportive Care in Cancer, vol. 31, no. 7, 401.
Caru, M, Abdullah, S, Qiu, L, Kanski, B, Gordon, B, Truica, CI, Vasakar, M, Doerksen, S & Schmitz, KH 2023, 'Women with metastatic breast cancer don't just follow step-count trends, they exceed them: an exploratory study', Breast Cancer Research and Treatment, vol. 200, no. 2, pp. 265-270.


Teslenko, I, Trudeau, J, Luo, S, Watson, CJW, Chen, G, Truica, CI & Lazarus, P 2022, 'Influence of Glutathione-S-Transferase A1*B Allele on the Metabolism of the Aromatase Inhibitor, Exemestane, in Human Liver Cytosols and in Patients Treated with Exemestane', Journal of Pharmacology and Experimental Therapeutics, vol. 382, no. 3, pp. 327-334.


Nesterova, D, Zhu, J, Kramer, C, Vasekar, M, Truica, C, Joshi, A, Hayes, M, Kessler, J, Saunders, EFH, Drabick, JJ & Joshi, M 2022, 'Group-led creative writing and behavioural health in cancer: A randomised clinical trial', BMJ Supportive and Palliative Care, vol. 12, no. 1, pp. 91-98.
Bluethmann, SM, Truica, C, Klepin, HD, Olsen, N, Sciamanna, C, Chinchilli, VM & Schmitz, KH 2021, 'Study design and methods for the using exercise to relieve joint pain and improve AI adherence in older breast cancer survivors (REJOIN) trial', Journal of Geriatric Oncology, vol. 12, no. 7, pp. 1146-1153.
Schmitz, KH, Schleicher, E, Doerksen, S, Truica, C, Cream, L, Kass, R, Farnan, M, Suess, R, Gordon, B, Zucker, D & Hayes, M 2021, 'Testing the acceptability and feasibility of a tablet-based supportive cancer platform for patients with metastatic breast cancer', Journal of Cancer Survivorship, vol. 15, no. 3, pp. 410-413.


Yin, M, Verschraegen, C, Vincent, VH, Patel, SM, George, T & Truica, CI 2020, 'Impact of lack of surgery on outcomes in elderly women with nonmetastatic breast cancer-A surveillance, epidemiology, and end results 18 population based study', Medicine (United States), vol. 99, no. 3, e18745.
Castaman, G, Borchiellini, A, Santagostino, E, Radossi, P, Aksu, S, Yilmaz, M, Serban, M, Uscatescu, V, Truica, C, Fasulo, MR, Mancuso, ME, Paladino, E, Valpreda, A, Guarnieri, C, Macchia, R, Scarpellini, M, Mathew, P & Morfini, M 2020, 'Non-Compartment and compartmental pharmacokinetics, efficacy, and safety of Kedrion FIX concentrate', European Journal of Pharmaceutical Sciences, vol. 153, 105485.
Schmitz, KH, Potiaumpai, M, Schleicher, EA, Wolf, LJ, Doerksen, SE, Drabick, JJ, Yee, NS, Truica, CI, Mohamed, AA, Shaw, BW & Farley, DC 2021, 'The exercise in all chemotherapy trial', Cancer, vol. 127, no. 9, pp. 1507-1516.